Clinical Trials Sponsored by Canadian Apheresis Group
Total 353 results
-
Hamilton Health Sciences CorporationHoffmann-La Roche; McMaster University; Canadian Apheresis GroupUnknownThrombotic Thrombocytopenic Purpura | Hemolytic Uremic SyndromeCanada
-
NCIC Clinical Trials GroupCascadian Therapeutics Inc.Completed
-
Canadian Cancer Trials GroupEndocyte; Prostate Cancer CanadaActive, not recruiting
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
NCIC Clinical Trials GroupOncothyreon Canada Inc.Completed
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
Canadian Cancer Trials GroupNot yet recruiting
-
Canadian Cancer Trials GroupRecruiting
-
Canadian Cancer Trials GroupCompletedRectal CancerUnited States, Canada
-
Canadian Cancer Trials GroupActive, not recruitingHepatocellular Carcinoma | Liver MetastasesCanada
-
Canadian Myeloma Research GroupActive, not recruiting
-
Canadian Cancer Trials GroupCompleted
-
Canadian Myeloma Research GroupCompleted
-
Canadian Cancer Trials GroupRecruiting
-
Canadian Myeloma Research GroupNot yet recruiting
-
Canadian Cancer Trials GroupActive, not recruiting
-
Canadian Cancer Trials GroupActive, not recruitingOropharyngeal CancerCanada
-
NCIC Clinical Trials GroupMerck Frosst Canada Ltd.Completed
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
UNICANCERCanadian Cancer Trials Group; GONO GROUPActive, not recruitingColon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)France, Canada
-
University Health Network, TorontoCanadian Urological Association; Canadian Urologic Oncology Group; Bladder Cancer...TerminatedBladder Cancer | Bladder Urothelial CarcinomaCanada
-
Canadian Cancer Trials GroupCanadian Cancer Society (CCS)RecruitingProstate Cancer MetastaticCanada
-
Canadian Cancer Trials GroupPfizerActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaCompleted
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingProstate CancerCanada
-
Canadian Cancer Trials GroupPfizerCompletedRefractory Lymphoma | Recurrent Lymphoma | Solid Tumours | Central Nervous SystemCanada
-
UNICANCERCanadian Cancer Trials GroupCompletedPancreatic Adenocarcinoma (Ductal Adenocarcinoma)Canada, France
-
Canadian Cancer Trials GroupAstraZenecaCompleted
-
Canadian Cancer Trials GroupPfizerCompleted
-
Canadian Cancer Trials GroupPfizerCompletedMetastatic Colorectal CancerCanada
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Canadian Cancer Trials GroupAstraZenecaCompletedGlioblastoma MultiformeCanada
-
Canadian Cancer Trials GroupNuBiyotaWithdrawnAdvanced Head and Neck Squamous Cell Carcinoma
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
SanofiCanadian Urologic Oncology GroupCompleted
-
Canadian Cancer Trials GroupNovartisRecruiting
-
Canadian Cancer Trials GroupAstraZenecaRecruiting
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingBladder CancerCanada, Spain, United Kingdom
-
Canadian Cancer Trials GroupPfizerActive, not recruitingAdvanced Rare TumoursCanada
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingOropharyngeal Squamous Cell CarcinomaCanada, Spain, Belgium, Italy
-
Canadian Cancer Trials GroupNovartisCompletedChronic Lymphocytic LeukemiaCanada
-
Canadian Cancer Trials GroupAstraZenecaCompletedNon Small Cell Lung CancerCanada
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
Canadian Cancer Trials GroupNovartisTerminatedMelanoma | Brain MetastasesCanada
-
NCIC Clinical Trials GroupCompleted
-
NCIC Clinical Trials GroupCompletedHead and Neck CancerCanada
-
NCIC Clinical Trials GroupTerminatedLiver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerCanada